Cost consequences of task-shifting intravitreal injections from physicians to nurses in a tertiary hospital in Norway

BACKGROUND: Anti-vascular endothelial growth factor is a medicine administered intravitreally by an injection to maintain visual acuity in patients with a variety of retinal diseases. The demand for this treatment has grown considerably in the westernized world the last two decades and will continue...

Descripción completa

Detalles Bibliográficos
Autores principales: Bolme, Stine, Austeng, Dordi, Morken, Tora Sund, Follestad, Turid, Halsteinli, Vidar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996986/
https://www.ncbi.nlm.nih.gov/pubmed/36890535
http://dx.doi.org/10.1186/s12913-023-09186-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996986/
https://www.ncbi.nlm.nih.gov/pubmed/36890535
http://dx.doi.org/10.1186/s12913-023-09186-0

Ejemplares similares